Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment

• HMB DUO:0000006 (version: 2019-01-07)health or medical or biomedical researchThis data use permission indicates that use is allowed for health/medical/biomedical purposes; does not include the study of population origins or ancestry.
• RU DUO:0000014 (version: 2019-01-07)research use onlyThis data use limitation indicates that use is limited to research purposes (e.g., does not include its use in clinical care).
• US DUO:0000026 (version: 2019-01-07)user specific restrictionThis data use modifier indicates that use is limited to use by approved users.

Access to data will be granted to qualified researchers for academic/non-commercial research use subject to signing a data transfer agreement which restricts publication and dissemination of the the dataset and which prohibits any attempt to re-identify any of the study patients. If you need to request access to this data set, please contact: Translational Oncogenomics Lab - Data Access Committee marco.gerlinger@icr.ac.uk

Access to data will be granted to qualified researchers for academic/non-commercial research use subject to signing a data transfer agreement which restricts publication and dissemination of the the dataset and which prohibits any attempt to re-identify any of the study patients. If you need to request access to this data set, please contact: Translational Oncogenomics Lab - Data Access Committee marco.gerlinger@icr.ac.uk